and how does it work?
Pharmaceutical, Analytical, Homeland Security
What is Klarite™ ?
Our technology in action
Broad Pathogen Screening
Infectious disease
Assay principles
Molecular diagnosticsD3 Technologies appoints new CEO
Glasgow, Scotland, 3rd February 2010: D3 Technologies Ltd, a world leading provider of trace level detection technologies based on the exploitation of Surface-Enhanced Raman Scattering (SERS) and Surface-Enhanced Resonance Raman Scattering (SERRS), today announced that it has appointed David Burns as its new Chief Executive Officer. He will lead the Company towards the international launch of its first in-vitro diagnostic (IVD) products, with the aim to establish D3 Technologies as a global player in the field of molecular diagnostics for human infectious diseases. Mr Burns has over 20 years of commercial life sciences experience, most recently as VP of Sales & Marketing with Cyntellect Inc, and before that as Head of Strategic Growth with GE Healthcare Life Sciences. ...find out more